Carvedilol Tablet, Film Coated
Product Images NDC 68071-4816

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68071-4816). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 4816 8)

Pdp (68071 4816 8)
This is a medication label for Carvedilol 6.25mg manufactured by NuCare Pharmaceuticals, Inc. The label contains information such as the lot number, NDC code, size of the bottle (180 tablets) and dosage instructions. It also includes a warning about possible side effects and instructions to store the medication at a controlled temperature and out of reach of children. The expiration date is not available.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
The text describes a survival analysis plot for the CAPRICORN clinical trial, where the intent-to-treat group was treated either with placebo or carvedilol. The plot shows the percentage of mortality on the vertical axis and time in months on the horizontal axis. The survival curve for carvedilol-treated patients was analysed, and it was found that patients treated with carvedilol had a significantly lower mortality rate than placebo-treated patients (P=0.03) after 30 months.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
The text contains a table consisting of subgroups in the CAPRICORN study and their corresponding effects on mortality. The subgroups are defined by age, gender, use of diuretics, angina, hypertension, diabetes, Killip class, heart rate, thrombolytic use, and PTCA use. The table presents hazard ratios for mortality among those subgroups.*
FDA Label Image

Carvedilol-chemical-structure (Structure)

Carvedilol-chemical-structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.